CRLBF - Cresco Labs Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue41,33410,3103,157.232
Cost of Revenue9179,1587,317.673
Gross Profit40,4171,152-4,160.441
Operating Expenses
Research Development---
Selling General and Administrative33,1265,2413,594.439
Non Recurring---
Total Operating Expenses34,73514,43810,934.848
Operating Income or Loss6,599-4,128-7,777.616
Income from Continuing Operations
Total Other Income/Expenses Net86814053.213
Earnings Before Interest and Taxes6,599-4,128-7,777.616
Interest Expense---
Income Before Tax7,467-3,988-7,724.403
Income Tax Expense4,374--
Minority Interest161,95014,25814,258
Net Income From Continuing Ops3,093-3,988-7,724.403
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-1,915-3,176-7,724.403
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-1,915-3,176-7,724.403